About Trinity Biotech Plc - ADR - Company Information, Overview, History and Profile
What does Trinity Biotech Plc - ADR do?
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
Trinity Biotech Plc - ADR Management structure
All Gross Remunerations are in USD
Mr. Aris Kekedjian
Chairman of the Board and Chief Executive Officer
1.17 M
2023
Gross Remuneration
Year
Mr. John Gillard
Director, President and Chief Executive Officer
710 K
2023
Gross Remuneration
Year
Mr. Ronan O'Caoimh
Director and Executive Advisor
80 K
2023
Gross Remuneration
Year
Dr. James Walsh, PhD
Executive Director and Director of Business Development
50 K
2023
Gross Remuneration
Year
Mr. Simon Dunne
Chief Accounting Officer
-
2023
Gross Remuneration
Year
Ms. Eibhlín Kelly
Chief Information Officer
-
2023
Gross Remuneration
Year
Trinity Biotech Plc - ADR Board of directors
All Gross Remunerations are in USD
Mr. Tom Lindsay
Independent Director
63 K
2023
Gross Remuneration
Year
Dr. Andrew Omidvar, PhD
Independent Director
10 K
2023
Gross Remuneration
Year
Mr. Ronan O'Caoimh
Director and Executive Advisor
-
2023
Gross Remuneration
Year
Dr. James Walsh, PhD
Executive Director and Director of Business Develo